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Enzymes with ribonucleolytic activity play a pivotal role in gene expression and cellular homeostasis by
altering the levels of cellular RNA. Ribonuclease A has been the most well studied of such enzymes whose
histidine residues (His12 and His119) play a crucial role in the catalytic mechanism of the protein. The ligands
chosen for this study, 2CMP and 3CMP, act as competitive substrate analog inhibitors of this enzyme.
Using molecular graphics software freely available for academic use, AutoDock and PyMol, we demon-
strate that substitution of either histidine residue by alanine causes marked changes in the distances
between these critical residues of the enzyme. The ligands in the docked conformation (particularly on
mutation of His119 to Ala) compensate for the altered free energy and hydrogen bonding abilities in these
new protein-ligand complexes.
Keywords: Docked conformation, substrate analog inhibitors, molecular graphics, hydrogen bonding, free
energy, protein-ligand complexes.
Ribonuclease A (RNase A1; EC 3.1.27.5) has been one of
the most studied enzymes of the last century, including the
landmark 1957 Anfinsen experiment demonstrating be-
yond doubt, for the first time, the cardinal importance of
amino acid sequence on the eventual shape of the folded
protein. Crystallized more than 50 years ago and the first
enzyme for which a correct amino acid sequence was
determined, RNase A was the third enzyme for which the
three-dimensional (3D) structure was determined [1].
Pioneering work relating to protein chemistry and enzy-
mology has been accomplished with RNase A (Fig. 1). The
predominant form of the enzyme present in bovine pan-
creas has been suffixed with an “A” in its name [2]. Re-
newed interest in this protein in the past decade has been
due to a large number of ribonuclease-type enzymes ex-
hibiting unusual biological activities [2–6]. Cellular RNA
levels are controlled post-transcriptionally by ribonucle-
ases of varying specificity. Angiogenin, neurotoxins, and
plant allergens are among the myriad of proteins with
RNase activity or significant homology to known RNases.
RNases are regulated by specific activators and inhibitors,
both natural and synthetic, including interferons and diet-
derived plant polyphenols and are thus potential targets
for the development of small and simple ligands as thera-
peutic interventions in such widespread diseases.
The enzyme catalyzes the cleavage of RNA via a cyclic
phosphate intermediate. In this enzyme, two histidines are
located near the bond to be cleaved. In the cyclization
step, His12 acts as a general base catalyst and His119 as a
general acid catalyst (His12 and His119 in bovine pancreatic
ribonuclease). These roles are reversed in the step involv-
ing hydrolysis of the cyclic phosphate intermediate (Fig. 2)
[6].
DNA lacks the hydroxyl group at the 2 position essential
for the formation of the cyclic intermediate and hence is
not cleaved by ribonuclease. The ribonuclease molecule
has a well defined binding cleft that comprises a ribose-
binding site, a phosphate-binding site (P), and a base-
binding site (B), as shown in Fig. 3.
Here we demonstrate the effect of mutation of each of
the aforementioned His residues on the binding of com-
petitive inhibitors 2-cytidine monophosphate (CMP) and
3CMP. To accomplish this, we have used a docking pro-
cedure that is used extensively in computer-aided drug
design. Macromolecular crystallography provides us with
the three-dimensional structure of large biomolecules, the
knowledge of which is essential for a complete under-
standing of its function. Docking studies have become one
of the most useful applications of this technique. The basic
feature of docking is to identify the site of interaction of
potential drug candidates to a target macromolecule [7].
The structure of the drug, its receptor, and the interac-
tions between them are analyzed closely to find the best
way to optimize geometry and activity or to give an indi-
cation of which molecules would be the most interesting to
synthesize [8, 9].
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MATERIALS AND METHODS
Materials
All software used for this analysis is free for academic use. The
simple approach gives an insight into the basic use of different
molecular graphics software presently in use and how further
analysis may be possible. A list of the sites from where data/
software has been obtained is provided below followed by a short
description of what is available.
The Protein Data Bank (www.rcsb.org) [10]—The Protein Data
Bank (PDB) is a worldwide repository for the processing and
distribution of 3D biological macromolecular structure data. Pres-
ently it has more than 25,000 structures determined by x-ray
diffraction. Protein structures may be downloaded from the site
with specific keywords or a PDB alphanumeric filename.
PyMol (Version 0.97, Delano Scientific, 2004, www.pymol.org)
[11]—PyMol is a Python-based visualization software. The files of
the proteins obtained from the PDB can be visualized using
PyMol. It has tools for measuring distances as well as identifying
different atoms. PyMol has been selected for the analysis of the
docking results.
AutoDock (Version 3.0, The Scripps Research Institute, ww-
w.scripps.edu) [12, 13]—The docking experiments were per-
formed using the docking software AutoDock 3.0 with the help
AutoDockTools, an accessory program that allows the user to
interact with AutoDock from a graphic user interface (GUI).
AutoDock is a suite of automated docking tools designed to
predict how small molecules/ligands, such as substrates or drug
candidates, bind to a receptor/protein of known 3D structure.
AutoDock (version 3.0) consists of three separate programs:
AutoDock, which performs the docking of the ligand to a set of
grids describing the target protein; AutoGrid, which precalculates
these grids; and AutoTors, which sets up which bonds will be
treated as rotatable in the ligand.
Preparation of the Macromolecule and Ligand
Files for AutoDock
Using the GUI of AutoDockTools (ADT) we prepared the files as
follows.
The Macromolecule File—The downloaded PDB files were first
read in ADT, added waters were removed, and polar hydrogens
were added. ADT then checked if the molecule had charges, and
if not it added Kollman charges [by default; ADT adds Kollman
charges for a peptide (determined by checking whether all of its
component residue names appear in the standard set of 20
commonly occurring amino acids) and Gasteiger charges if not
so]. Finally, solvation parameters were added and the files saved
as molecule.pdbqs (where “q” and “s” represent charge and
solvation, respectively).
The Ligand File—In a similar procedure, the ligand files were
read in ADT, nonpolar hydrogens were merged, and charges were
added. ADT then determined the best root (the best root is the
atom in the ligand with the smallest or largest subtree; in case of
a tie, if either atom is in a cycle, it is picked as the root, and if
neither or both is in a cycle, the first found is picked). Next we
defined rotatable bonds in the ligand, making all amide bonds
nonrotatable, and set the number of active torsions to fewest
atoms. The ligand file was then saved with a ligand.out.pdbq
extension (“q” representing charge).
Preparation of the Grid Parameter File—For the calculation of
docking interaction energy, it is necessary to create a 3D box
(grid) in which the protein molecule is enclosed. The grid volume
should be large enough to allow the ligand to rotate freely, even
when the ligand is in its most fully extended conformation. The
parameters required to create such a grid are stored in the grid
parameter file, molecule.gpf. The autogrid3 job was then run
FIG. 1. Structure of wild-type RNase A (PDB filename
1FS3.pdb). The His12 and His119 residues have been labeled.
FIG. 2. Mechanism of action of RNase A. a, cyclization step:
His12 acts as the base and His119 as the acid. b, hydrolysis step:
The roles of the His residues are reversed.
FIG. 3. Schematic diagram depicting the amino acid resi-
dues in the binding pockets of RNase A. P and B represent the
phosphate- and base-binding sites, respectively.
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FIG. 4. Schematic diagram of the procedure.
FIG. 5. Labeling schemes for the ligands 2CMP (left) and 3CMP (right).
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to create a map for every atom type in the ligand and create
the corresponding macromolecular file with the extension
molecule.glg.
Preparation of Docking Parameter File—The docking parame-
ter file, which instructs AutoDock about the ligand to move, the
map files to use, and other properties defined for the ligand, was
created. The search methods of AutoDock include the Monte
Carlo simulated annealing method, the genetic algorithm, local
search, and the hybrid genetic algorithm with local search. The
latter is also referred to as the Lamarckian genetic algorithm
because offsprings are allowed to inherit the local search adap-
tations of their parents, and this was the chosen algorithm for the
analysis.
Finally the autodock job was run from the GUI of ADT, and the
docked ligand files (.dlg extension) were used for study. The .dlg
files were read in ADT as well as in PyMol to calculate the
interatomic distances in the docked ligand-protein complexes.
The entire procedure is given below in the flowchart (Fig. 4).
FIG. 6. The top panel represents 2CMP (green) complexed with RNase A (1JVU from the PDB), and the bottom panel shows
the ligand (red) docked onto 1FS3 using AutoDock. Both macromolecules are in same orientation, and the active site residues Thr45,
His12, and His119 have been highlighted. The His12 (NE2)-C-2-P (P) distances are shown for comparison.
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RESULTS AND DISCUSSION
The docked conformation of 2CMP onto 1FS3 (wild-
type RNase A) shows marked resemblance in orientation
and distances with neighboring residues in the active site
pocket of the enzyme with that reported in the PDB as
1JVU (2CMP complexed with wild-type RNase A) (Fig. 5).
Being a competitive inhibitor, 2CMP docks onto the active
site pocket of the protein and hydrogen bonding becomes
possible with nearby residues Thr45, His12, and His119.
Our results are further consolidated by 3CMP, which
docks comparatively weakly onto 1FS3, albeit still in the
active site cavity (final docked energy  –9.38 kcal/mol
compared with –10.72 kcal/mol for 2CMP), when its
orientation and interresidue distances are compared with
1RPF (the reported structure in the PDB of 3CMP com-
plexed with wild-type RNase A). The root mean square
deviation of superposed structures of 1FS3 (wild type)
with docked 2CMP and 1JVU (from the PDB) was only
0.014 (Fig. 6).
Marked changes occur on mutating the active site his-
tidines (His12 and His119) to alanine in terms of orientation
of the ligand in the protein-ligand docked complex. In
1C9V (His12 mutated to Ala), the docking of 2CMP is
weakened, and final docked energy is reduced (less neg-
ative). The two possible orientations of His119 reported in
1C9V.pdb are situated about 5 and 4 Å further away than
in 1FS3 in terms of the His119 (ND1)-C-2-P (O1P) (our
numbering scheme is illustrated in Fig. 5) distance in their
proximal and distal stereochemistries, respectively. Inter-
estingly, the orientation of the ligand is such that the His119
(ND1)-C-2-P (O2P) distances (not shown in Table I) are a
bit shorter than the His119 (ND1)-C-2-P (O1P) distances,
the former being 6.47 and 5.68 Å (proximal and distal
histidines) and the latter 8.88 and 8.03 Å, respectively. The
substituted Ala12 residue of course has its  carbon closer
than the  carbon of the original His residue, owing to the
absence of the imidazole ring of histidine.
The phosphate-recognition site P1 of the wild-type en-
zyme has His119 oriented in a direction opposite to that of
1C9V. This feature has affected the binding of the ligand to
the active site region, which is reflected in the measurement
of distances between, and the ligand and these residues
(Table I), implying that the absence of His12 at the phos-
phate-binding site significantly alters ligand conformation. At
the same time, Thr45 (N)-C-2-P (O2) and Thr
45 (OG1)-C-2-P
(N3) distances are more or less conserved in 1C9V, implying
that the base-binding site is not affected (Fig. 7).
Distinctive changes occur on mutation of the His119
residue to Ala (1C9X) with the final docked energy being
–7.16 kcal/mol, an increase of 3.56 kcal/mol. The stereo-
chemistry of the docked ligand shifts from the active site
pocket, the Thr45 (N)-C-2-P (O2) and Thr
45 (OG1)-C-2-P
(N3) distances increasing more than 2-fold to 6.01 and
5.47 Å, respectively (Fig. 6). Concurrently, the His12 (NE2)-
C-2-P (O1P) and His12 (CB)-C-2-P (P) distances remain
relatively conserved as in the wild-type form (the latter
elongated to 4.4 Å), suggesting that the absence of His119
at the phosphate-binding site greatly alters ligand stereo-
chemistry, but the phosphate-binding site is not affected
significantly (Fig. 7).
When 3CMP is chosen as the ligand, the root mean
square deviation of superposed structures of 1FS3 (wild
type) with 3CMP docked and 1RPF was 0.033. The al-
ready weaker binding is altered to a smaller extent on
mutating His12 to Ala (1C9V), and in fact the absence of the
His12 residue facilitates 3CMP binding to a small extent as
reflected in a slightly greater docking energy (more nega-
tive), plausibly to accommodate for altered hydrogen
bonding and free energy conditions (Fig. 8). However,
similar trends in internuclear distances occur as for
2CMP, that is increased His119 (ND1)-C-3-P (O1P) dis-
tances by about 2–3 Å with proximal and distally oriented
His119 and conservation of Thr45 (N)-C-3-P (O2) and Thr45
(OG1)-C-3-P (N3) lengths (slight increase). As in 2CMP,
binding of the ligand is drastically weakened in terms of
the final docked energy in 1C9X, 3CMP having a value of
TABLE I
Comparison of critical distances of residues in docked conformation of 2CMP and 3CMP on RNase A (wild-type 1FS3 and mutants
1C9V [His12 to Ala]) and 1C9X [His119 to Ala]) obtained using AutoDock, with reported values in the PDB
(1JVU and 1RPF, respectively) [all distances in angstroms]
PDB ID Final dockedenergy
Thr45 (N)
C-2-P
(O2)
Thr45 (OG1)
C-2-P (N3)
His12 (NE2)
C-2-P
(O1P)
His12
(CB)-C-2-P
(P)
His119
(ND1)-C-2P
(O1P)
His119
(CB)
C-2-P (P)
kcal/mol
2CMP
1FS3a –10.72 2.67 2.58 2.70 7.14 3.84 5.02
1JVU (reported) – 2.82 2.63 2.56 7.15 3.87 4.76
1C9V (His12 to Ala) a)8.88 a)5.39
–10.20 2.73 3.03 – 4.19b b)8.03 b)5.54
1C9X (His119 to Ala) –7.16 6.01 5.47 4.40 7.04 – 5.22b
3CMP
1FS3c –9.38 2.66 3.08 4.64 8.27 3.83 4.39
1RPF (reported) – 2.72 2.89 4.66 7.63 3.24 4.36
1C9V (His12 to Ala) a)6.54 a)5.51
–10.50 3.01 3.65 – 4.06 b)5.33 b)5.67
1C9X (His119 to Ala) –8.13 6.03 4.56 2.93 6.96 – 5.18b
a Final docked energy, –10.72 kcal/mol; final intermolecular energy, –10.79 kcal/mol; estimated Ki, 1.01e-07; final internal energy of ligand,
0.06 kcal/mol.
b Distances with corresponding alanine residue.
c Final docked energy, –9.38 kcal/mol; final intermolecular energy, –9.32 kcal/mol; estimated Ki, 1.2e-06; final internal energy of ligand,
–0.05 kcal/mol.
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–8.13 kcal/mol. In this docked protein (1C9X)-3CMP
complex, Thr45 (N)-C-3-P (O2) and Thr45 (OG1)-C-3-P
(N3) distances increase nearly 2-fold to 6.03 and 4.56 Å,
respectively, although His12 (NE2)-C-3-P (O1P) and His12
(CB)-C-3-P (P) distances remain intact, rather than de-
crease to a small degree to accommodate for the changes
in hydrogen bonding and molecular energy constraints, as
compared with the wild-type enzyme (Fig. 9). In this con-
text, His12 (NE2)-C-3-P (O1P) and His12 (NE2)-C-3-P
(O3P) distances decrease to 2.93 and 2.83Å, respectively.
FIG. 7. The top panel shows the ligand 2CMP docked onto 1C9V (red), and the bottom panel shows the legend docked onto
1C9X (green). In both cases, the macromolecules are orientated as in Fig. 5, the same residues are highlighted (Thr45, His12, His119),
and the Thr45 (N)-C-2-P (O2) distances are marked for comparison.
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CONCLUSION
The docking results as consolidated by comparison with
reported protein-ligand complexes from the PDB demon-
strate the relative accuracy and ease of using molecular
graphics software like AutoDock. Mutations in critical ac-
tive site histidines of RNase A has marked implications for
substrate analog inhibitor/ligand bindings of 2CMP and
3CMP as indicated by significant changes of docking
energy and interatomic distances in the protein-ligand
docked complexes.
The absence of His12 orients the His119 in the opposite
direction, which shifts the phosphate away from the His119
FIG. 8. The top panel shows the ligand 3CMP (red) complexed with RNase (1RPF from the PDB), and the bottom panel 3CMP
(green) docked onto the active site residues Thr45, His12, and His119 have been highlighted; the His12 (NE2)-C-2-P (P) distances
are shown for comparison.
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residue. This implies that the change in His12 by Ala12
affects the phosphate-binding site of the ligand, whereas
the base-binding site remains unaffected. Again, the ab-
sence of His119 shifts the six-membered ring of the base
(ligand) away from Thr45, hence reducing the interaction
with it, whereas the phosphate remains at a proximal dis-
tance from His12. This implies that the change in His119 by
Ala119 affects the base-binding site, whereas the phos-
FIG. 9. The top panel shows the ligand 3CMP docked onto 1C9V (red), and the bottom panel shows the ligand docked onto
1C9X (green). In both cases, the macromolecules are orientated similarly, and the same residues are highlighted (Thr45, His12, His119);
the Thr45 (N)-C-2-P (O2) distances have been marked for comparison.
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phate-binding site remains unaffected.
This exercise provides an opportunity to explore the
docking procedure and compare the results obtained with
actual crystal structures available in the PDB. Our analysis
here is a simple demonstration of a generalized scheme
widely applicable to structural bioinformatics for docking
and model development in therapeutic drug design.
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